Earlier, from "aboutlawsuits":
In a blistering editorial, writers for the Journal of the American Medical Association (JAMA), lambasted GlaxoSmithKline’s activities in research over potential side effects of Avandia, which some say are responsible for tens of thousands of heart attacks and deaths. The authors are calling for new, stringent, medical and scientific journal reforms that would ensure integrity and minimize the ability of corporations to obfuscate scientific data.
As an example, the authors, Drs. Catherine DeAngelis and Phil Fontanarosa, cite GlaxoSmithKline’s RECORD trial, which was purported to study the heart attack problems with the Avandia. The editorial calls Glaxo’s RECORD trial “a disturbing example of inappropriate conduct surrounding an industry-sponsored clinical trial of [Avandia] and reveals a situation in which concerns about preserving market share apparently trumped concerns about the potential for causing patient harm.”